Alnylam Pharmaceuticals (ALNY) Net Equity Issued and Repurchased (2012 - 2019)
Alnylam Pharmaceuticals (ALNY) posted Net Equity Issued and Repurchased of -$18.1 million for Q2 2019, down 104.74% on a QoQ basis from $381.9 million in Q1 2019.
Alnylam Pharmaceuticals (ALNY) Net Equity Issued and Repurchased (2012 - 2019) Analysis & Trends
Alnylam Pharmaceuticals' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at -$18.1 million for Q2 2019.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$18.1 million in Q2 2019, while the trailing twelve-month figure through Mar 2020 was -$18.1 million (down 101.55% YoY) and the FY2019 annual result came in at $381.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was -$18.1 million for Q2 2019 at Alnylam Pharmaceuticals, down from $381.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $784.5 million in Q4 2017 and bottomed at -$18.1 million in Q2 2019.
- A 3-year average of $411.2 million and a median of $439.2 million in 2015 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -18.10 Mn |
| Jun 30, 2019 | -18.10 Mn |
| Mar 31, 2019 | 381.90 Mn |
| Mar 31, 2019 | 381.90 Mn |
| Dec 31, 2017 | 784.48 Mn |
| Dec 31, 2017 | 784.48 Mn |
| Mar 31, 2015 | 496.40 Mn |
| Mar 31, 2015 | 496.40 Mn |
| Mar 31, 2013 | 173.57 Mn |
| Mar 31, 2013 | 173.57 Mn |
| Mar 31, 2012 | 86.80 Mn |
| Mar 31, 2012 | 86.80 Mn |